These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11015639)

  • 1. Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: a case report.
    Cozza KL; Swanton EJ; Humphreys CW
    Psychosomatics; 2000; 41(5):452-3. PubMed ID: 11015639
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant hepatic failure in the context of reinstituting valproate use.
    Rej S; Chen T; Edwards M; Zicherman V
    Psychosomatics; 2014; 55(3):303-4. PubMed ID: 24360531
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver toxicity in epidemiological cohorts.
    Becker S
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S49-55. PubMed ID: 14986275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine.
    de Maat MM; Beijnen JH; Schellens JH; Mulder JW
    J Infect; 2005 Apr; 50(3):262-4. PubMed ID: 15780424
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).
    Podzamczer D; Andrade-Villanueva J; Clotet B; Taylor S; Rockstroh JK; Reiss P; Domingo P; Gellermann HJ; de Rossi L; Cairns V; Soriano V
    HIV Med; 2011 Jul; 12(6):374-82. PubMed ID: 21518220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset hepatitis and prolonged deterioration in hepatic function associated with nevirapine therapy.
    Clarke S; Harrington P; Condon C; Kelleher D; Smith OP; Mulcahy F
    Int J STD AIDS; 2000 May; 11(5):336-7. PubMed ID: 10824944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
    Bundow D; Rosoff L; Aboulafia DM
    AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
    Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
    Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
    [No Abstract]   [Full Text] [Related]  

  • 10. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancytopenia and valproic acid: a dose-related association.
    Oluboka OJ; Haslam D; Gardner DM
    J Am Geriatr Soc; 2000 Mar; 48(3):349-50. PubMed ID: 10733073
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy.
    Lyons F; Hopkins S; Kelleher B; McGeary A; Sheehan G; Geoghegan J; Bergin C; Mulcahy FM; McCormick PA
    HIV Med; 2006 May; 7(4):255-60. PubMed ID: 16630038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART].
    Lackmann GM; Schmidt B; Niehues T
    Hautarzt; 2003 Aug; 54(8):765-6. PubMed ID: 12942192
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ergenyl chronospheres in bipolar disorders].
    Grunze H
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515285
    [No Abstract]   [Full Text] [Related]  

  • 17. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients.
    Dejesus E; Mills A; Bhatti L; Conner C; Storfer S
    Int J Clin Pract; 2011 Dec; 65(12):1240-9. PubMed ID: 21999631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity associated with nevirapine use.
    Baylor MS; Johann-Liang R
    J Acquir Immune Defic Syndr; 2004 Apr; 35(5):538-9. PubMed ID: 15021321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.